
|Articles|July 1, 2004
CIBA Vision sells Epi-LASIK technology to Australian firm
Atlanta-An Australian medical device company will take over the Epi-LASIK surgical product line as part of CIBA Vision's divestiture of its surgical business (also see Page 1). Norwood Abbey Ltd., Melbourne, Australia, bought the Centurion SES system and EpiEdge epikeratome separator for $10 million. The company paid $1 million when it signed the agreement in May, and it signed a note with CIBA Vision for $9 million for the balance of the technology and inventory price.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5




























